Fidelity monitoring across the seven studies in the Consortium of Hospitals Advancing Research on Tobacco (CHART)

Tobacco Induced Diseases

Andrea H. Waltje⁵  Hilary A. Tindle²  Taneisha S. Scheuermann⁹  Erin Rogers⁸  Carrie Kirby¹  Kathleen F. Harrington⁴  Jeffrey L. Fellows⁶  Sharon E. Cummins⁷  Sonia A. Duffy³ 

[1]Moores Cancer Center, University of California, San Diego, 9500 Gilman Drive, MC0905, La Jolla 92093, CA, USA

[2]Department of Medicine, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 370, Nashville 37203, TN, USA

[3]VA Center for Clinical Management Research, HSR&D Center of Excellence, 2215 Fuller Road, Ann Arbor 48105, MI, USA

[4]Division of Pulmonary Medicine, University of Alabama at Birmingham, 1900 University Blvd., THT541-G1, Birmingham 35294-0006, AL, USA

[5]University of Michigan, Internal Medicine, Brehm Tower, Room 6115, 1000 Wall Street, Ann Arbor 48109-5714, MI, USA

[6]Kaiser Permanente Center for Health Research, 3800 N Interstate Ave, Portland 97227, OR, USA

[7]Department of Family Medicine and Public Health, University of California, San Diego, 9500 Gilman Drive, MC0905, La Jolla 92093, CA, USA

[8]Department of Population Health, New York University School of Medicine, 227 E. 30th St., New York, NY & VA New York Harbor Healthcare System, 423 E. 23rd St., New York, NY, USA

[9]Department of Preventive Medicine and Public Health, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City 66160, KS, USA

关键词: Fidelity;    Inpatient;    Cessation;    Smoking;   

Others  :  1224495
DOI  :  10.1186/s12971-015-0056-5

 received in 2015-04-15, accepted in 2015-08-20,  发布年份 2015

【 摘 要 】

Background

This paper describes fidelity monitoring (treatment differentiation, training, delivery, receipt and enactment) across the seven National Institutes of Health-supported Consortium of Hospitals Advancing Research on Tobacco (CHART) studies. The objectives of the study were to describe approaches to monitoring fidelity including treatment differentiation (lack of crossover), provider training, provider delivery of treatment, patient receipt of treatment, and patient enactment (behavior) and provide examples of application of these principles.

Methods

Conducted between 2010 and 2014 and collectively enrolling over 9500 inpatient cigarette smokers, the CHART studies tested different smoking cessation interventions (counseling, medications, and follow-up calls) shown to be efficacious in Cochrane Collaborative Reviews. The CHART studies compared their unique treatment arm(s) to usual care, used common core measures at baseline and 6-month follow-up, but varied in their approaches to monitoring the fidelity with which the interventions were implemented.

Results

Treatment differentiation strategies included the use of a quasi-experimental design and monitoring of both the intervention and control group. Almost all of the studies had extensive training for personnel and used a checklist to monitor the intervention components, but the items on these checklists varied widely and were based on unique aspects of the interventions, US Public Health Service and Joint Commission smoking cessation standards, or counselor rapport. Delivery of medications ranged from 31 to 100 % across the studies, with higher levels from studies that gave away free medications and lower levels from studies that sought to obtain prescriptions for the patient in real world systems. Treatment delivery was highest among those studies that used automated (interactive voice response and website) systems, but this did not automatically translate into treatment receipt and enactment. Some studies measured treatment enactment in two ways (e.g., counselor or automated system report versus patient report) showing concurrence or discordance between the two measures.

Conclusion

While fidelity monitoring can be challenging especially in dissemination trials, the seven CHART studies used a variety of methods to enhance fidelity with consideration for feasibility and sustainability.

Trial registration

Dissemination of Tobacco Tactics for hospitalized smokers. Clinical Trials Registration No. NCT01309217.

Smoking cessation in hospitalized smokers. Clinical Trials Registration No. NCT01289275.

Using “warm handoffs” to link hospitalized smokers with tobacco treatment after discharge: study protocol of a randomized controlled trial. Clinical Trials Registration No. NCT01305928.

Web-based smoking cessation intervention that transitions from inpatient to outpatient. Clinical Trials Registration No. NCT01277250.

Effectiveness of smoking-cessation interventions for urban hospital patients. Clinical Trials Registration No. NCT01363245.

Comparative effectiveness of post-discharge interventions for hospitalized smokers. Clinical Trials Registration No. NCT01177176.

Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals. Clinical Trials Registration No. NCT01236079.

【 授权许可】

   
2015 Duffy et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Korda H. Bringing evidence-based interventions to the field: the fidelity challenge. Journal of Public Health Management and Practice. 2013; 19(1):1-3.
• [2]Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M et al.. Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH behavior change consortium. Health Psychol. 2004; 23(5):443-51.
• [3]Stein KF, Sargent JT, Rafaels N. Intervention research - Establishing fidelity of the independent variable in nursing clinical trials. Nurs Res. 2007; 56(1):54-62.
• [4]Campbell BK, Manuel JK, Manser ST, Peavy KM, Stelmokas J, McCarty D et al.. Assessing fidelity of treatment delivery in group and individual 12-step facilitation. J Subst Abus Treat. 2013; 44:169-76.
• [5]Guydish J, Campbell BK, Manuel JK, Delucchi KL, Le T, Peavy M et al.. Does treatment fidelity predict client outcomes in 12-Step Facilitationfor stimulant abuse? Drug Alcohol Depend. 2014; 134:330-6.
• [6]Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008; 41(3–4):327-50.
• [7]Santacroce SJ, Maccarelli LM, Grey M. Intervention fidelity. Nurs Res. 2004; 53(1):63-6.
• [8]Elliott DS, Mihalic S. Issues in disseminating and replicating effective prevention programs. Prev Sci. 2004; 5(1):47-53.
• [9]Borrelli B, Sepinwall D, Ernst D, Bellg AJ, Czajkowski S, Breger R et al.. A new tool to assess treatment fidelity and evaluation of treatment fidelity across 10 years of health behavior research. J Consult Clin Psychol. 2005; 73(5):852-60.
• [10]Borrelli B. The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials. J Public Health Dent. 2011; 71:S52-63.
• [11]McHugh RK, Murray HW, Barlow DH. Balancing fidelity and adaptation in the dissemination of empirically-supported treatments: The promise of transdiagnostic interventions. Behav Res Ther. 2009; 47(11):946-53.
• [12]Spillane V, Byrne MC, Byrne M, Leathem CS, O’Malley M, Cupples ME. Monitoring treatment fidelity in a randomized controlled trial of a complex intervention. J Adv Nurs. 2007; 60(3):343-52.
• [13]Moncher FJ, Prinz RJ. Treatment fidelity in outcome studies. Clin Psychol Rev. 1991; 11(3):247-66.
• [14]Riley WT, Stevens VJ, Zhu S-H, Morgan G, Grossman D. Overview of the consortium of hospitals advancing research on tobacco (chart). Trials. 2012; 13:122. BioMed Central Full Text
• [15]Duffy SA, Ronis DL, Titler MG, Blow FC, Jordan N, Thomas PL et al.. Dissemination of the nurse-administered Tobacco Tactics intervention versus usual care in six Trinity community hospitals: study protocol for a comparative effectiveness trial. Trials. 2012; 13:125. BioMed Central Full Text
• [16]Cummins S, Zhu S-H, Gamst A, Kirby C, Brandstein K, Klonoff-Cohen H et al.. Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial. Trials. 2012; 13:128. BioMed Central Full Text
• [17]Grossman E, Shelley D, Braithwaite RS, Lobach I, Goffin A, Rogers E et al.. Effectiveness of smoking-cessation interventions for urban hospital patients: study protocol for a randomized controlled trial. Trials. 2012; 13:126. BioMed Central Full Text
• [18]Harrington KF, McDougal JA, Pisu M, Zhang B, Sadasivam RS, Houston TK et al.. Web-based smoking cessation intervention that transitions from inpatient to outpatient: study protocol for a randomized controlled trial. Trials. 2012; 13:123. BioMed Central Full Text
• [19]Fellows JL, Mularski R, Waiwaiole L, Funkhouser K, Mitchell J, Arnold K et al.. Health and economic effects from linking bedside and outpatient tobacco cessation services for hospitalized smokers in two large hospitals: study protocol for a randomized controlled trial. Trials. 2012; 13:129. BioMed Central Full Text
• [20]Reid ZZ, Regan S, Kelley JHK, Streck JM, Ylioja T, Tindle HA et al.. Comparative effectiveness of post-discharge strategies for hospitalized smokers: study protocol for the Helping HAND 2 randomized controlled trial. BMC Public Health. 2015; 15(109):1484.
• [21]Richter KP, Faseru B, Mussulman LM, Ellerbeck EF, Shireman TI, Hunt JJ et al.. Using “warm handoffs” to link hospitalized smokers with tobacco treatment after discharge: study protocol of a randomized controlled trial. Trials. 2012; 13:127. BioMed Central Full Text
• [22]Rigotti NA, Clair C, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. The Cochrane Database of Systematic Reviews. 2012; 5:CD001837.
• [23]Rigotti NA, Regan S, Levy DE, Japuntich S, Chang Y, Park E et al.. Sustained care intervention and postdischarge smoking cessation among hospitalized adults: A randomized clinical trial. JAMA. 2014; 312(7):719-28.
• [24]Duffy SA, Karvonen-Gutierrez C, Ewing LA, Smith PM. Veterans Integrated Services Network (VISN) 11 Tobacco Tactics Team. Implementation of the Tobacco Tactics Program in the Department of Veterans Affairs. J Gen Intern Med. 2010; 25 Suppl 1:3-10.
• [25]Fore A, Karvonen-Gutierrez C, Talsma A, Duffy SA. Nurses’ delivery of the Tobacco Tactics intervention at a Veterans Affairs Medical Center. J Clin Nurs. 2014; 23(15–16):2162-9.
• [26]Joint Commission on Accreditation of Healthcare Organizations. Tobacco Treatment Measures (TTM). 2011; http://www.jointcommission.org/assets/1/6/Tobacco%20Treatment%20Measures%20List1.PDF. Accessed 2 February 2012.
• [27]United States Public Health Service Commissioned Corps. Tobacco Smoking Cessation. 2011; http://ccmis.usphs.gov/ccbulletin/articles/smoking_cessation_02_2011.aspx. Accessed 23 March 2015.
• [28]Campbell BK, Buti A, Fussell HE, Srikanth P, McCarty D, Guydish JR. Therapist predictors of treatment delivery fidelity in a community-based trial of 12-step facilitation. Am J Drug Alcohol Abuse. 2013; 39(5):304-11.
• [29]Katz DA, Holman JE, Johnson SR, Hillis SL, Adams SL, Fu SS et al.. Implementing best evidence in smoking cessation treatment for hospitalized veterans: results from the VA-BEST Trial. The Joint Commission Journal on Quality and Patient Safety. 2014; 40(11):493-503.
• [30]Leventhal H, Friedman MA. Does establishing fidelity of treatment help in understanding treatment efficacy? Comment on Bellg et al. (2004). Health Psychol. 2004; 23(5):452-6.
• [31]Addis ME, Krasnow AD. A national survey of practicing psychologists’ attitudes toward psychotherapy treatment manuals. J Consult Clin Psychol. 2000; 68(2):331-9.
• [32]Barlow DH, Levitt JT, Bufka LF. The dissemination of empirically supported treatments: a view to the future. Behav Res Ther. 1999; 37:S147-62.
• [33]Backer T. Finding the balance: program fidelity and adaptation in substance abuse prevention: A state-of-the-art review. Center for Substance Abuse Prevention, Rockville, MD; 2001.